(lp0
S'CorMedix Inc  Due For A Rebound Insider Financial - Apr 13, 2017 CorMedix Inc. , the biopharmaceutical company developing treatments for infectious and inflammatory diseases, has almost gotten kill according to its chart.CorMedix Inc. Secures First European Commercial Collaboration for Neutrolin - StockhouseCorMedix Inc.  Upgraded at Zacks Investment Research - The Cerbat Gem'
p1
aS"CorMedix Inc. Reports Fourth Quarter and Full Year 2016 Financial Results and ... Yahoo Finance - Mar 17, 2017 BEDMINSTER, NJ / ACCESSWIRE / March 17, 2017 / CorMedix Inc. , a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory&nbsp;...CORMEDIX INC.  Files An 8-K Results of Operations and Financial ... - Market ExclusiveCorMedix's  CEO Khoso Baluch on Q4 2016 Results - Earnings Call Transcript - Seeking Alpha"
p2
aS'CorMedix Inc. CRMD  Wall Street Journal - Feb 11, 2011 News CorMedix Inc.CRMD. Significant News Only. 03/23/17; Press Release.  CorMedix Inc. Makes NYSE MKT Section 610 Public Announcement.'
p3
aS'Brokerage Firm Analyst Consensus on CorMedix, Inc.  AmpliPhi ... Rives Journal - 19 hours ago CorMedix, Inc.  shares have been labeled a top pick by Beta Research as it meets the A+ criteria outlined by the firm.'
p4
aS"BRIEF-Cormedix Inc full year 2016 loss per share $0.65 Reuters - Mar 17, 2017 Reuters is the news and media division of Thomson Reuters. Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news&nbsp;..."
p5
aS'CorMedix Inc. Announces Dismissal of Securities Class Action Lawsuit and ... Yahoo Finance - Dec 21, 2016 BEDMINSTER, NJ / ACCESSWIRE / December 21, 2016 / CorMedix Inc. , a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory&nbsp;...'
p6
aS'Analyst Target Price &amp; Stock Review on CorMedix, Inc.  Midway Monitor - 17 hours ago Analysts on the sell-side are offering a consensus Buy rating on shares of CorMedix, Inc. . Using the following ratings scale: 1.0 Strong Buy, 2.0 Buy, 3.0 Hold, 4.0 Sell and 5.0 Strong Sell, analysts have an average recommendation of 1.50 on ...'
p7
aS'What Happened to CorMedix Inc.  MicroCap Daily - Jul 29, 2015 CorMedix Inc.  recently saw a parabolic rise to highs of $10.40 a share off its base at just over $1. Since then the stock has been in steep decline heading back to where it started.'
p8
aS'Stock Trading Focus for CorMedix, Inc.  BVN - 17 hours ago Looking at shares of CorMedix, Inc. , the company presently has a Gross Margin  ratio of -0.006528.'
p9
aS'CorMedix Inc. : Strong Sell On Partner Failure, -91.4% Downside: Pump ... ValueWalk - Jun 29, 2015 I believe CorMedix is one of the most brazen, worthless biotech shells of insider enrichment I have ever seen. Bankruptcy documents show Cormedix  is based on a 1970s-era catheter product acquired for &lt;$1m cash the last time this&nbsp;...CorMedix: Strong Sell On Partner Failure, Misleading Data And Paid Stock ... - Seeking Alpha'
p10
a.